Medicines / Indswift Laboratories / Glymat

GlymatGliclazide + Metformin

Glymat is marketed by Indswift Laboratories. 1 pack on NPPA's price list for July 2026, containing Gliclazide + Metformin.

Packs listed
1
Lowest MRP
₹67.60
Per unit
₹6.76
Price-controlled packs
0 of 1
Dosage forms
1

Packs and prices

  1. ₹67.60Glymat 80/500 mg Tablet 10Gliclazide + Metformin Tablet 80/500 mg · ₹6.76 per tablet

The same composition from other brands

Packs with the identical filed composition, form and strength. A different brand is not automatically interchangeable: ask your doctor or pharmacist.

Gliclazide + Metformin Tablet 80/500 mg

  1. ₹1.48/tabletGlypen MF · 10 tabletMorepen Laboratories · MRP ₹14.80
  2. ₹1.75/tabletDaozide M · 10 tabletUniventis Medicare · MRP ₹17.50
  3. ₹2.00/tabletGlatix M · 10 tabletInvision Medi Sciences · MRP ₹20.00
  4. ₹2.06/tabletGlamit · 10 tabletZen Labs India · MRP ₹20.63
  5. ₹2.28/tabletGlycitop M · 10 tabletHealing Pharma India · MRP ₹22.81
  6. ₹3.80/tabletGefor · 10 tabletPsychotropics India · MRP ₹38.00
  7. ₹3.90/tabletGlucozid M · 10 tabletMedley Pharmaceuticals · MRP ₹39.00
  8. ₹4.12/tabletK Gem · 15 tabletBlue Cross Laboratories · MRP ₹61.87

96 other brands of this composition on the price list; the 8 lowest per tablet are shown. All Gliclazide + Metformin packs

The company

Indswift Laboratories has 338 packs on the price list. Company record

Prices are the maximum retail prices each company filed with the National Pharmaceutical Pricing Authority (NPPA) for July 2026, read from NPPA's Pharma Sahi Daam service on 2 Oct 2026. A price in a shop can be lower; it may not lawfully be higher. Failed batches are those CDSCO and state laboratories declared not of standard quality. This is a record of prices and filings, not medical advice: do not change a medicine without your doctor or pharmacist. Source: NPPA and CDSCO, Government of India. About this record.

COUNTERFOIL / CONTACT

Contact us.

How can we help?

Stored privately by Counterfoil. Your email is used only to respond to your enquiry.